Drug Shortage Report for TEVA-CLOBETASOL

Last updated on 2024-10-17 History
Report ID 236359
Drug Identification Number 01910280
Brand name TEVA-CLOBETASOL
Common or Proper name CLOBETASOL 0.05% OINTMENT
Company Name TEVA CANADA LIMITED
Market Status MARKETED
Active Ingredient(s) CLOBETASOL PROPIONATE
Strength(s) 0.05%
Dosage form(s) OINTMENT
Route of administration TOPICAL TOPICAL
Packaging sizes (GTIN)

Click here to see a list of all reports for this drug.

(See additional packaging sizes)
Additional packaging sizes 50g
ATC code D07AD
ATC description CORTICOSTEROIDS, PLAIN
Reason for shortage Disruption of the manufacture of the drug.
Anticipated start date
Actual start date 2024-08-28
Estimated end date 2024-11-10
Actual end date 2024-10-16
Shortage status Resolved
Updated date 2024-10-17
Company comments
Health Canada comments
Tier 3 Status No
Contact Address 30 NOVOPHARM COURT
TORONTO, ONTARIO
CANADA M1B 2K9
Company contact information

Version History

Click on "Compare" below to view the full report history and compare to other versions.

Version Number Date Updated Language
v6 2024-10-17 French Compare
v5 2024-10-17 English Compare
v4 2024-09-05 French Compare
v3 2024-09-05 English Compare
v2 2024-08-30 French Compare
v1 2024-08-30 English Compare

Showing 1 to 6 of 6